Abstract
BACKGROUND: Although flow cytometric detection of myelodysplastic syndrome (MDS) with the Ogata score has a high specificity, its sensitivity for low-grade MDS is low. Additional markers are needed to improve its diagnostic reliability. Therefore, we investigated the diagnostic performance of the Ki-67 proliferation index in bone marrow (BM) cell populations for detection of MDS.
METHODS: BM aspirates from 50 MDS patients and 20 non-clonal cytopenic controls were analyzed with flow cytometry to determine the Ogata score and the Ki-67 proliferation indices in different cell populations.
RESULTS: Ki-67 proliferation indices alone could be used to detect MDS with a sensitivity of up to 80 % and specificity of up to 70 %. Combining the Ogata score with the Ki-67 proliferation index of erythroid cells significantly improved its sensitivity for detection of MDS from 66 % to 90 %, while maintaining a specificity of 100 %. Particularly, the sensitivity for detection of low-grade MDS improved from 56 % to 91 %.
CONCLUSIONS: This is the first study using Ki-67 proliferation indices to detect MDS and shows their particularly high diagnostic sensitivity for detection of low-grade MDS. Integration of the Ki-67 proliferation index of erythroid cells into the Ogata score significantly improved its sensitivity without loss of the high specificity.
Original language | English |
---|---|
Article number | 106789 |
Number of pages | 8 |
Journal | Leukemia Research |
Volume | 113 |
DOIs | |
Publication status | Published - Feb 2022 |
Keywords
- Aged
- Aged, 80 and over
- Biomarkers/analysis
- Bone Marrow Cells/metabolism
- Cell Proliferation
- Erythroid Cells/metabolism
- Female
- Granulocytes/metabolism
- Humans
- Ki-67 Antigen/analysis
- Male
- Middle Aged
- Mitotic Index
- Monocytes/metabolism
- Myelodysplastic Syndromes/diagnosis
- ROC Curve
- Severity of Illness Index
- Flow cytometry
- MDS
- Ki-67
- NEOPLASMS
- VALIDATION
- Proliferation
- Ogata score
- FLOW-CYTOMETRY